DAVIS ROBERT T. JR. 4

What Happened Robert T. Davis Jr., EVP & President, TR&DT of Integra LifeSciences Holdings Corp. (IART), received a grant of 11,180 restricted stock units (RSUs) on July 1, 2026. The RSUs were awarded with a $0 purchase price (a non-cash equity award) and are recorded as a derivative award on the Form 4. These RSUs represent contingent rights to one share of common stock each and will vest in full on the second anniversary of the grant, subject to continued service.

Key Details

• Transaction date: 2026-07-01; Form 4 filed: 2026-07-06.
• Transaction type/code: Award/Grant (A) of 11,180 RSUs at $0.00 (derivative).
• Vesting: All RSUs vest in full on the second anniversary of the grant date, subject to continued service (per footnotes).
• Plan: Granted under the Integra Fifth Amended and Restated 2003 Equity Incentive Plan.
• Shares owned after transaction: Not specified in this filing excerpt.
• Timeliness: Filing was dated five days after the grant (Form 4 normally must be filed within two business days), which may indicate a late filing.

Context This was an equity compensation grant (RSUs), not an open-market purchase or sale. RSU grants are routine executive compensation and only convert to actual shares if/when vesting conditions are met; they do not necessarily signal immediate buying or selling intent.